152 related articles for article (PubMed ID: 33895159)
1. A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease.
Luo J; Xie M; Hou Y; Ma W; Jin Y; Chen J; Li C; Zhao K; Chen N; Xu L; Ji Y; Zhang Q; Zheng Y; Yu D
Biochem Pharmacol; 2021 Jun; 188():114582. PubMed ID: 33895159
[TBL] [Abstract][Full Text] [Related]
2. A novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells.
Luo J; Hou Y; Ma W; Xie M; Jin Y; Xu L; Li C; Wang Y; Chen J; Chen W; Zheng Y; Yu D
Biochem Pharmacol; 2021 Jul; 189():114458. PubMed ID: 33556337
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA hsa-miR-25-3p suppresses the expression and drug induction of CYP2B6 in human hepatocytes.
Jin Y; Yu D; Tolleson WH; Knox B; Wang Y; Chen S; Ren Z; Deng H; Guo Y; Ning B
Biochem Pharmacol; 2016 Aug; 113():88-96. PubMed ID: 27311985
[TBL] [Abstract][Full Text] [Related]
4. Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression.
Heo MJ; Kim TH; You JS; Blaya D; Sancho-Bru P; Kim SG
Gut; 2019 Apr; 68(4):708-720. PubMed ID: 29475852
[TBL] [Abstract][Full Text] [Related]
5.
Lim SYM; Alshagga MA; Alshawsh MA; Ong CE; Pan Y
Drug Metab Pers Ther; 2021 Aug; 37(1):55-67. PubMed ID: 35146975
[TBL] [Abstract][Full Text] [Related]
6. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HOX transcript antisense intergenic RNA depletion protects against alcoholic hepatitis through the microRNA-148a-3p/sphingosine 1-phosphate receptor 1 axis.
Chen D; Lu P; Sun T; Ding A
Cell Tissue Res; 2023 Dec; 394(3):471-485. PubMed ID: 37851113
[TBL] [Abstract][Full Text] [Related]
8. Altered regulation of miR-34a and miR-483-3p in alcoholic hepatitis and DDC fed mice.
Liu H; French BA; Li J; Tillman B; French SW
Exp Mol Pathol; 2015 Dec; 99(3):552-7. PubMed ID: 26403328
[TBL] [Abstract][Full Text] [Related]
9. Identification of miRNAs that regulate human CYP2B6 expression.
Nakano M; Iwakami C; Fukami T; Nakajima M
Drug Metab Pharmacokinet; 2021 Jun; 38():100388. PubMed ID: 33872945
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells.
Yu D; Green B; Tolleson WH; Jin Y; Mei N; Guo Y; Deng H; Pogribny I; Ning B
Biochem Pharmacol; 2015 Nov; 98(1):215-23. PubMed ID: 26296572
[TBL] [Abstract][Full Text] [Related]
11. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregulation in alcoholic hepatitis mice.
Eguchi A; Yan R; Pan SQ; Wu R; Kim J; Chen Y; Ansong C; Smith RD; Tempaku M; Ohno-Machado L; Takei Y; Feldstein AE; Tsukamoto H
J Mol Med (Berl); 2020 Jul; 98(7):1021-1034. PubMed ID: 32556367
[TBL] [Abstract][Full Text] [Related]
13. MiR-451a ameliorates alcoholic hepatitis via repressing HDAC8-mediated proinflammatory response.
Du B; Tan XH; Cheng L; Wang F; Zhang HF
Kaohsiung J Med Sci; 2020 Nov; 36(11):904-910. PubMed ID: 32643864
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA hsa-miR-1301-3p Regulates Human
Wang X; Zhao Y; Luo J; Xu L; Li X; Jin Y; Li C; Feng M; Wang Y; Chen J; Hou Y; Zhao Q; Zhao J; Ning B; Zheng Y; Yu D
Mol Pharmacol; 2020 Aug; 98(2):120-129. PubMed ID: 32499331
[TBL] [Abstract][Full Text] [Related]
15. MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation.
Kugler N; Klein K; Zanger UM
Biochem Pharmacol; 2020 Jan; 171():113725. PubMed ID: 31758923
[TBL] [Abstract][Full Text] [Related]
16. A systematic evaluation of microRNAs in regulating human hepatic CYP2E1.
Wang Y; Yu D; Tolleson WH; Yu LR; Green B; Zeng L; Chen Y; Chen S; Ren Z; Guo L; Tong W; Guan H; Ning B
Biochem Pharmacol; 2017 Aug; 138():174-184. PubMed ID: 28438567
[TBL] [Abstract][Full Text] [Related]
17. Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells.
Yu D; Tolleson WH; Knox B; Jin Y; Guo L; Guo Y; Kadlubar SA; Ning B
Biochem Pharmacol; 2015 Dec; 98(4):671-80. PubMed ID: 26428001
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9.
Rieger JK; Reutter S; Hofmann U; Schwab M; Zanger UM
Drug Metab Dispos; 2015 Jun; 43(6):884-8. PubMed ID: 25802328
[TBL] [Abstract][Full Text] [Related]
19. Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma.
Yu D; Green B; Marrone A; Guo Y; Kadlubar S; Lin D; Fuscoe J; Pogribny I; Ning B
Sci Rep; 2015 Feb; 5():8534. PubMed ID: 25704921
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation.
Zeng L; Chen Y; Wang Y; Yu LR; Knox B; Chen J; Shi T; Chen S; Ren Z; Guo L; Wu Y; Liu D; Huang K; Tong W; Yu D; Ning B
Biochem Pharmacol; 2017 Sep; 140():139-149. PubMed ID: 28552654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
